Adjuvant Capital Email Format
Venture Capital and Private Equity PrincipalsNew York, United States11-50 Employees
Adjuvant Capital is a Brooklyn-based life sciences firm focused on global health. It concentrates on supporting ambitious companies that target high-burden and neglected diseases, aiming to advance innovative health solutions. The team is a small to mid-sized group focused on enabling progress in underserved health markets. Its customers are life sciences companies developing health technologies addressing global health needs. The organization positions itself as a facilitator for progress in markets where access to care remains limited and neglected diseases persist. In October 2025, Adjuvant Capital participated in the World Bank and IMF Annual Meetings, where its representatives discussed approaches to address overlooked health challenges.